Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance

The Molecular and Clinical Genetics Panel is weighing the Galleri test's clinical evidence today; Medicare coverage could follow FDA approval

FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Health & Medicine

More from Wednesday 23 September →